The global sales of syringe filling machine are estimated to be worth USD 425.5 million in 2024 and are anticipated to reach a value of USD 644.0 million by 2034. Sales are projected to rise at a CAGR of 4.2% over the forecast period between 2024 and 2034. The revenue generated by syringe filling machine in 2023 was USD 410.9 million. The industry is anticipated to exhibit a Y-o-Y growth of 3.5% in 2024.
In 2024, pharmaceutical companies hold more than 43% of the value share in the syringe filling machine market. They require high precision filling systems that are sterile and efficient since vaccine production is on a massive scale, and other injectable drugs require such strict and advanced filling technologies due to stringent regulatory standards set on companies.
Other changes in the biologics and personalized medicines area would push more demand for focused filling solutions. Thus pharma companies are likely to concentrate on syringe filling machines as these will help them automate their production lines and will make compliance easier.
Global Syringe Filling Machine Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 410.9 million |
| Estimated Size, 2024 | USD 425.5 million |
| Projected Size, 2034 | USD 644.0 million |
| Value-based CAGR (2024 to 2034) | 4.2% |
The market for vacuum filling machines is likely to reach USD 162.6 million revenue by the end of forecast period. This will be primarily due to the fact that this machine plays a very crucial role in various industries that demand precise and contamination free filling processes.
In pharmaceuticals, food and beverage, and cosmetics, the accuracy of dosing and reduced exposure of the product to air make vacuum filling technology highly valued. On the other hand, machines increase demand for sterile packaging, especially for liquid pharmaceuticals and sensitive cosmetics. Furthermore, consumers increasingly demand high quality preservative free produces, which favors the growth of the market.
Automatic syringe filling machine is anticipated to register a 4.2% CAGR in the forecast period, since the pharmaceutical companies require high throughput and efficient production. Injectable, vaccines, and biologics are widely used medicines that lead the companies to use automated systems that can deal with heavy volumes of production in high accuracy and sterility.
This reduces human error, the risk of contamination, and time taken for production that strictly adheres to regulatory compliance, there is also an increasing trend towards customized medicines, capable of packaging more than one formulation at any one time.
The syringe filling machine industry is set to experience moderate growth during the forecast period. It is projected to create an incremental opportunity of USD 233.1 million and is predicted to rise 1.5 times the current market value through 2034.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The below table presents the expected CAGR for the global syringe filling machine market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 4.5%, followed by a slightly lower growth rate of 4.3% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 4.5% (2023 to 2033) |
| H2 | 4.3% (2023 to 2033) |
| H1 | 4.1% (2024 to 2034) |
| H2 | 3.4% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 4.1% in the first half and remain relatively moderate at 3.4% in the second half. In the first half (H1) the market witnessed a decrease of 20 BPS while in the second half (H2), the market witnessed an increase of 30 BPS.
Increasing Demand for Injectable Drugs
The growing trend of chronic conditions across the world such as diabetes, arthritis, and cardiovascular diseases create the constant need for injectable drugs such as insulin, biologics, and mono clonal antibodies to be administrated through injection during treatment.
The covid-19 pandemic further added an element of urgency in the matter of immediate vaccine requirements, and it has also thrust a spate of demand into the market for syringe filling machines so that mass quantities of prefilled syringes can be produced.
There has been a need for a specific dosing, conditions as far as sterility goes, and the right volume regarding biologics and biosimilar given these medications are used to manage complex diseases, all provided by syringe filling machines.
This has therefore given cause to increased investment into syringe filling technology of superior quality with the aim to fill rapidly growing requirement for reliable safe and efficient injectable drug delivery solutions.
Emphasis on Sterility and Aseptic Processing
Growing stringent regulations in the drug formulation process are placing more pressures on the improvements of sterile requirements to ensure that filling of the drugs does not have a tendency to cause contaminants. The manufacturer are rapidly investing in advanced sterilizing and aseptic filling technologies, including isolator technology and closed system, which create controlled conditions that minimize exposure to such externals.
This is majorly important for injectable as contamination can have serious medical concerns with injected drugs. Other contributing factors are the increasing demand for single use technologies as such systems significantly simplify cleaning and validation processes, which further minimize the potential for cross contamination.
Using single use components will allow manufacturer to have better sterility levels in addition to making their production much easier. This trend represents an industry trend towards high standards of safety in pharmaceutical manufacturing.
High Initial Cost Limits the Expansion
Advanced technology as well as automation are integrated with syringe filing machines so that they have a very high initial cost. It remains a big barrier to the small pharmaceutical companies since these require huge investment in precision engineering, quality components, as well as sophisticated automation systems.
These are usually very expensive and beyond the budgets that the small companies cannot provide. Other costs also contribute to the maintenance and the training. Therefore these could opt for cheaper, manual alternatives or would have to experience slowdowns in their ramp up periods.
Principal Consultant
The global syringe filling machine industry recorded a CAGR of 2.0% during the historical period between 2019 and 2023. The growth of the syringe filling machine industry was positive as it reached a value of USD 410.9 million in 2023 from USD 335.7 million in 2019.
During historic period, a considerable number of factors have had consistence in growth in this global syringe filling machine market. The increasing cases of chronic diseases and the widespread requirements for vaccines due to the covid-19 pandemic are major factors that led to a manifold increase in demand for syringe filling machines.
The increasing pressure in the demand for sterility further influenced manufacturer to adopt the latest technology available, such as high speed automated filling lines for large volumes with accuracy. The market increased in 2021 due to global vaccination but sales proved stable for 2022 to 2023 as the immediate effects of the pandemic waned. However, it remains strong due to interest biologics and maintained demand for injectable drugs.
The demand for syringe filling machines for forecast period will be driven by the continued growth of pharmaceutical and healthcare industry.
Biologics and biosimilar also will continue to grow combined with self-administration through prefilled syringes and auto injectors, while technical innovation in the form of automation and IoT integration will enable better production efficiency and precision in the process, encouraging upgrading of filling equipment by the manufacturer growing pharmaceutical sectors in emerging markets couples with continued attention to sustainability and single use technologies.
Overall, the historic period was positive period was positive due to the sudden demand for injectable drugs but the future forecast does look positive. Technology will continue to advance and the emphasis on sterility and safety will gain more importance and the increasing use of biologics and self-administration trends will surely be the bright side for syringe filling machine supplier as well.
Tier 1 companies in the global syringe filling machine industry include OPTIMA packaging group GmbH, Cytiva, Dara Pharmaceutical Packaging, and Harro Höfliger Verpackungsmaschinen GmbH with market revenue above USD 40 million.
These manufacturers are market leaders in syringe filling machine within global industry having extensive production capacity, different product offerings, and extensive manufacturing expertise. These companies are capturing around 40% to 45% of global market share in the syringe filling machine industry.
Tier 2 of the global syringe filling machines industry incorporates companies like Syntegon Technology GmbH, IMA Group, Groninger & Co. GmbH, Marchesini Group, SHINVA Medical Instrument Co., Ltd., Stäubli International AG with revenue of USD 4 to 40 million. They have limited presence, and well-maintained knowledge but may not have expertise and advanced manufacturing technology.
Tier 3 category in the global syringe filling machine market includes the small-scale players of the region with revenue below USD 4 million. These companies fulfil the local market demand and are recognized as an unorganized market. They have a country level presence, limited manufacturing facilities, and expertise in local market needs.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis of the syringe filling machine market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, South Asia & Pacific, East Asia, Western Europe, Eastern Europe, and others, is provided.
North America and Western Europe have contributed 45.7% of market share in 2024. MEA and South Asia Pacific projected to grow at 4.9% and 5.6% during forecast period.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 3.2% |
| Germany | 2.7% |
| UK | 3.0% |
| Canada | 4.5% |
| India | 6.0% |
| China | 4.8% |
| Japan | 3.9% |
| Brazil | 3.4% |
United States is anticipated to reach almost 76% of value share in North America. Disease Control and Prevention reported that more than half of adults around 51.8% had at least 1 of 10 diagnosed with one of the chronic conditions including arthritis, cancer, chronic obstructive pulmonary diseases, coronary heart disease, current asthma, diabetes, hepatitis, hypertension, stroke, and weak or failing kidneys, and 27.2% of adults in the country had more than one chronic conditions.
In diseases management, these injectable drugs gain importance for such chronic patients as there are requirements of insulin in the case of diabetes, immunotherapy in autoimmunity diareses, or pain management with cardiovascular drugs that have to be injected directly. There is a high upsurge of chronic diseases in the USA and highly driving demand for syringe filling machine.
An aging population further exaggerates demand because elderly are more prone to chronic disorders, and such patients more frequently require injectable treatment.
Thus pharmaceutical companies are investing in syringe filling machines and are focusing on the delivery of prefilled syringe filling machines and are focusing on the delivery of prefilled syringes with efficient, accurate, and scalable production without compromising safety for long treatment protocols.
Japan is anticipated to grow at a compound annual growth rate of 3.9% with an incremental growth of USD 6.5 million during the assessment year. World Economic Forum reported that 1 in 10 people in Japan are having age of 80 or older, and the country is consistently rated as having the world’s oldest population. Japan’s 29.1% of population is aged 65 or older which will have a profound impact on the oral syringe market.
Demand for prefilled syringes and oral syringes is increasing since elderly people often require long term medication management, such as injectable treatments for conditions like diabetes, arthritis, and cardiovascular diseases.
These demand requirements call for efficient and safe production by filling machines in both scale and precision that will meet the requirements of the elderly population in Japan. In addition, a growing trend of home health care and self-administration treatments in Japan adds to the fire concerning user friendly, prefilled syringes, making investments into advanced syringe filing technology required to meet increased healthcare needs.
The section contains information about the leading segments in the industry. Plastic syringe is projected to grow at 4.6% CAGR through 2034. 1000 to 5000 syringes per hour capacity machines is projected to grow at 4.5% by end of 2034.
| Syringe Type | Glass Syringe |
|---|---|
| Value Share (2034) | 62% |
The glass syringes are anticipated to capture 60% of the market in syringe filling machines by 2034. This is because glass syringes are more compatible with injectable drugs, especially biologics and high potency drugs, as opposed to plastic syringes that can easily cause chemical reactions.
With the advancements in the biologic therapies, sensitive to contamination, and which require high quality packaging, pharmaceutical companies prefer glass syringes. In addition, glass syringes offer better durability and precise dosing, which aligns well with stringent pharmaceutical standards and the need for reliable, sterile drug delivery which is driving the sales of syringe filling machines designed for glass syringes.
| Capacity | 1000 to 5000 Syringes Per Hour |
|---|---|
| Value Share (2034) | 39% |
1000 to 50000 syringes per hour capacity of syringe filling machine is observed to be more adopted in industry. The industry embraces these machines because they hit an optimal balance between efficiency and flexibility for mid-scale production needs.
This capacity range suits pharmaceutical companies needing to produce significant, controlled batches to meet demand for specialized or high value medications, such as biologics and injectable therapies without complexity and cost of ultra-high speed machines.
These machines allow for filling which is very important to guarantee accuracy and sterility with sensitive formulation. This capacity range will also support the variety needed for different syringe sizes, which is an absolute need for companies that must be changed between products or are for smaller niche markets.
The syringe filling machine market is highly competitive. Leading companies in the market have developed most advanced, high speed machines. They rely on R&D to develop automated, flexible machines that meet the demands of biologics and personalized medicine.
The smaller regional players focus on cost effective solutions tailored to the local market. They tend to specialize in mid capacity machines. The partnerships, merger, and acquisition are evident to allow the companies to expand into more markets and improve their scale of operations. The competition is innovative as all players are compelled to meet stringent regulatory and pharmaceutical needs that change fast.
Recent Industry Developments in Syringe Filling Machine Market
Syringe filling machine industry is divided into automatic, semiautomatic, and manual.
Syringe filling machine industry is segregated into glass syringe and plastic syringe. Both are further classified as prefilled syringe bulk syringe.
The industry is classified by vacuum filling, pressure filling, time pressure filling, peristaltic pump filling, and piston pump filing.
The industry is classified by up to 1000 syringes per hour, 1000 to 5000 syringes per hour, 5000 to 100000 syringes per hour, and above 100000 syringes per hour.
The industry is classified by end use as pharmaceutical companies, biotech firms, contract manufacturing organization (CMO), research laboratories, and hospitals & clinics.
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, and Middle East and Africa (MEA), have been covered in the report.
The global syringe filling machine industry is projected to witness CAGR of 4.2% between 2024 and 2034.
The global syringe filling machine industry stood at USD 410.9 million in 2023.
The global syringe filling machine industry is anticipated to reach USD 644 million by 2034 end.
South Asia and Pacific is set to record the highest CAGR of 5.6% in the assessment period.
The key players operating in the global syringe filling machine industry include includes OPTIMA packaging group GmbH, Cytiva, Dara Pharmaceutical Packaging, and Harro Höfliger Verpackungsmaschinen GmbH.
Explore Packaging Insights
View Reports
Syringe Filling Machine Market
